Status:
UNKNOWN
Prophylactic Pancreatic Stent for the Prevention of Post Operative Pancreatic Fistula
Lead Sponsor:
Peking Union Medical College Hospital
Conditions:
Pancreatic Fistula
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Postoperative pancreatic fistula (POPF) remains one of the most harmful complications after pancreatic resection. Some studies have indicated that endoscopic pancreatic stenting was effective in the t...
Eligibility Criteria
Inclusion
- All patients scheduled for elective segmental pancreatectomy
Exclusion
- Subjects for whom ERCP procedures are contraindicated
- If female, pregnant based on a positive hCG serum or an in vitro diagnostic test result or breast-feeding
- Age less than 18 year
- Emergency surgery
- Previous pancreatic surgery
Key Trial Info
Start Date :
January 22 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2022
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT03822676
Start Date
January 22 2019
End Date
May 1 2022
Last Update
January 30 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China, 100730